Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | POU2AF1 |
| Upstream (Parents) |
|---|
| (<<) IGLV2-11///IGLV2-18///IGLV2-23 → POU2AF1 |
| (<<) IGKC → POU2AF1 |
| (<<) IGLL3 → POU2AF1 |
| Downstream (Children) |
|---|
| POU2AF1 → SQSTM1 (>>) |
| POU2AF1 → KCNQ1 (>>) |
| POU2AF1 → TSFM (>>) |
| POU2AF1 → HLA-DQA1 (>>) |
| POU2AF1 → IGHD (>>) |
| POU2AF1 → DTNB (>>) |
| POU2AF1 → IGHV4-31///IGHV@///IGHM///IGHG1///IGHA1 (>>) |
| POU2AF1 → TTTY2 (>>) |
| POU2AF1 → SIRPG (>>) |
| POU2AF1 → PMS2L4 (>>) |
| POU2AF1 → PTGER2 (>>) |
| POU2AF1 → DOCK9 (>>) |
